investment

Views & Analysis

When biotech meets reality TV - Starton Therapeutics faces t...

Starton Therapeutics is bypassing the traditional venture capital route to raise money for its transdermal delivery technology that delivers medicine through the skin.

R&D

The Alderley Park Discovery Podcast: The journey to accessin...

Episode 3 of the Alderley Park Discovery Podcast covers how to successfully access life science funding and investment, highlighting a range of ways companies can attract investors.

News

UK chancellor Sunak urged to boost pharma and biotech in bud...

UK chancellor Rishi Sunak has been urged to recognise the leading role that pharma companies are playing in the economy in this week’s budget.

News

Disgraced biotech investor Woodford plans revival amid UK li...

Disgraced investor Neil Woodford plans to start a new biotech investment firm as he seeks to capitalise on a booming UK life sciences industry and rebuild his reputation following the colla

News

The rise and rise of digital health investment

UK biotech investment at record levels amid COVID-19

New figures have confirmed that the UK’s biotech sector received a massive boost from the COVID-19 pandemic last year, with investment levels soaring to £2.8 billion ($3.8 billion) from a l

News

Digital-health-literacy--the-bright-tail-of-the-comet

Olive Tree Ventures closes $170m dedicated digital health fu...

Israel’s specialist venture capital firm, Olive Tree Ventures (OTV) has closed a fund worth $170 million, with plans to expand its portfolio of digital health firms.

When biotech meets reality TV - Starton Therapeutics faces t...

The Alderley Park Discovery Podcast: The journey to accessin...

UK chancellor Sunak urged to boost pharma and biotech in bud...

Disgraced biotech investor Woodford plans revival amid UK li...

UK biotech investment at record levels amid COVID-19

Olive Tree Ventures closes $170m dedicated digital health fu...

Immunovant's thyroid eye disease drug flunks pivotal trials

Using AI-driven synthetic personas to take your insights fur...

investment

Editor's Picks